Chronic pain affects hundreds of millions of people worldwide. Chronic pain syndromes include persistent headaches, back pain, as well as pain associated with arthritis, trauma, surgeries, diabetes, and cancer. Despite the tremendous socioeconomic impact of these medical problems, few therapeutic options are currently available. Opioid drugs commonly used for chronic pain management are addictive. In the United States alone, the total economic burden of prescription opioid misuse approaches $80 billion a year.

 

Neuresta is committed to addressing this global healthcare problem with science-based innovation. Our mission is to help those suffering from chronic pain by fulfilling the unmet need for effective and safe medications. Since chronic pain is usually localized, we develop local analgesics for strategic treatments of affected areas of the body. Our lead candidates are expected to offer long-lasting pain relief without systemic side effects.